SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-006916
Filing Date
2019-08-02
Accepted
2019-08-02 12:09:32
Documents
76
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20190630x10q.htm   iXBRL 10-Q 2079909
2 EX-31.1 clvs-20190630ex311605167.htm EX-31.1 19886
3 EX-31.2 clvs-20190630ex312051886.htm EX-31.2 20109
4 EX-32.1 clvs-20190630ex321860e93.htm EX-32.1 8006
5 EX-32.2 clvs-20190630ex322dfbe28.htm EX-32.2 8086
  Complete submission text file 0001558370-19-006916.txt   8218302

Data Files

Seq Description Document Type Size
6 EX-101.SCH clvs-20190630.xsd EX-101.SCH 55146
7 EX-101.CAL clvs-20190630_cal.xml EX-101.CAL 82531
8 EX-101.DEF clvs-20190630_def.xml EX-101.DEF 146758
9 EX-101.LAB clvs-20190630_lab.xml EX-101.LAB 556482
10 EX-101.PRE clvs-20190630_pre.xml EX-101.PRE 361867
11 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20190630x10q_htm.xml XML 1572170
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 19994997
SIC: 2834 Pharmaceutical Preparations